-
1
-
-
84897970506
-
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
-
N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, P.W. Wilson, K.M. Eddleman, N.M. Jarrett, K. LaBresh, L. Nevo, J. Wnek, J.L. Anderson, J.L. Halperin, N.M. Albert, B. Bozkurt, R.G. Brindis, L.H. Curtis, D. DeMets, J.S. Hochman, R.J. Kovacs, E.M. Ohman, S.J. Pressler, F.W. Sellke, W.K. Shen, S.C. Smith Jr., G.F. Tomaselli American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 S1 S45
-
(2014)
Circulation
, vol.129
, pp. S1-S45
-
-
Stone, N.J.1
Robinson, J.G.2
Lichtenstein, A.H.3
Bairey Merz, C.N.4
Blum, C.B.5
Eckel, R.H.6
Goldberg, A.C.7
Gordon, D.8
Levy, D.9
Lloyd-Jones, D.M.10
McBride, P.11
Schwartz, J.S.12
Shero, S.T.13
Smith, S.C.14
Watson, K.15
Wilson, P.W.16
Eddleman, K.M.17
Jarrett, N.M.18
LaBresh, K.19
Nevo, L.20
Wnek, J.21
Anderson, J.L.22
Halperin, J.L.23
Albert, N.M.24
Bozkurt, B.25
Brindis, R.G.26
Curtis, L.H.27
DeMets, D.28
Hochman, J.S.29
Kovacs, R.J.30
Ohman, E.M.31
Pressler, S.J.32
Sellke, F.W.33
Shen, W.K.34
Smith, S.C.35
Tomaselli, G.F.36
more..
-
2
-
-
77953711938
-
Unintended effects of statins in men and women in England and Wales: Population based cohort study using the QResearch database
-
J. Hippisley-Cox, and C. Coupland Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database BMJ 340 2010 c2197
-
(2010)
BMJ
, vol.340
, pp. c2197
-
-
Hippisley-Cox, J.1
Coupland, C.2
-
3
-
-
84875420550
-
Use of high potency statins and rates of admission for acute kidney injury: Multicenter, retrospective observational analysis of administrative databases
-
C.R. Dormuth, B.R. Hemmelgarn, J.M. Paterson, M.T. James, G.F. Teare, C.B. Raymond, J.P. Lafrance, A. Levy, A.X. Garg, P. Ernst Canadian Network for Observational Drug Effect Studies Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases BMJ 346 2013 f880
-
(2013)
BMJ
, vol.346
, pp. f880
-
-
Dormuth, C.R.1
Hemmelgarn, B.R.2
Paterson, J.M.3
James, M.T.4
Teare, G.F.5
Raymond, C.B.6
Lafrance, J.P.7
Levy, A.8
Garg, A.X.9
Ernst, P.10
-
4
-
-
84901618597
-
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials
-
S. Bangalore, R. Fayyad, G.K. Hovingh, R. Laskey, L. Vogt, D.A. DeMicco, D.D. Waters Treating to New Targets Steering Committee and Investigators Statin and the risk of renal-related serious adverse events: analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials Am J Cardiol 113 2014 2018 2020
-
(2014)
Am J Cardiol
, vol.113
, pp. 2018-2020
-
-
Bangalore, S.1
Fayyad, R.2
Hovingh, G.K.3
Laskey, R.4
Vogt, L.5
DeMicco, D.A.6
Waters, D.D.7
-
5
-
-
84923378330
-
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome
-
A. Sarma, C.P. Cannon, J. de Lemos, J.L. Rouleau, E.F. Lewis, J. Guo, J.L. Mega, M.S. Sabatine, and M.L. O'Donoghue The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome J Am Heart Assoc 3 2014 e000784
-
(2014)
J Am Heart Assoc
, vol.3
, pp. e000784
-
-
Sarma, A.1
Cannon, C.P.2
De Lemos, J.3
Rouleau, J.L.4
Lewis, E.F.5
Guo, J.6
Mega, J.L.7
Sabatine, M.S.8
O'Donoghue, M.L.9
-
6
-
-
84924981752
-
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel
-
M. Banach, M. Rizzo, P.P. Toth, M. Farnier, M.H. Davidson, K. Al-Rasadi, W.S. Aronow, V. Athyros, D.M. Djuric, M.V. Ezhov, R.S. Greenfield, G.K. Hovingh, K. Kostner, C. Serban, D. Lighezan, Z. Fras, P.M. Moriarty, P. Muntner, A. Goudev, R. Ceska, S.J. Nicholls, M. Broncel, D. Nikolic, D. Pella, R. Puri, J. Rysz, N.D. Wong, L. Bajnok, S.R. Jones, K.K. Ray, and D.P. Mikhailidis Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel Arch Med Sci 11 2015 1 23
-
(2015)
Arch Med Sci
, vol.11
, pp. 1-23
-
-
Banach, M.1
Rizzo, M.2
Toth, P.P.3
Farnier, M.4
Davidson, M.H.5
Al-Rasadi, K.6
Aronow, W.S.7
Athyros, V.8
Djuric, D.M.9
Ezhov, M.V.10
Greenfield, R.S.11
Hovingh, G.K.12
Kostner, K.13
Serban, C.14
Lighezan, D.15
Fras, Z.16
Moriarty, P.M.17
Muntner, P.18
Goudev, A.19
Ceska, R.20
Nicholls, S.J.21
Broncel, M.22
Nikolic, D.23
Pella, D.24
Puri, R.25
Rysz, J.26
Wong, N.D.27
Bajnok, L.28
Jones, S.R.29
Ray, K.K.30
Mikhailidis, D.P.31
more..
-
7
-
-
84942789057
-
Statin adverse events in primary prevention: Between randomized trials and observational studies
-
I. Mansi Statin adverse events in primary prevention: between randomized trials and observational studies Am J Med Sci 350 2015 330 337
-
(2015)
Am J Med Sci
, vol.350
, pp. 330-337
-
-
Mansi, I.1
-
8
-
-
84876553028
-
The controversy of a wider statin utilization: Why?
-
I. Mansi, and E. Mortensen The controversy of a wider statin utilization: why? Expert Opin Drug Saf 12 2013 327 337
-
(2013)
Expert Opin Drug Saf
, vol.12
, pp. 327-337
-
-
Mansi, I.1
Mortensen, E.2
-
9
-
-
84928584490
-
Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers
-
D. Khalil, M. Boktor, E.M. Mortensen, C.R. Frei, and I. Mansi Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusers Am J Cardiol 115 2015 1396 1401
-
(2015)
Am J Cardiol
, vol.115
, pp. 1396-1401
-
-
Khalil, D.1
Boktor, M.2
Mortensen, E.M.3
Frei, C.R.4
Mansi, I.5
-
10
-
-
84945470638
-
Statins and new-onset diabetes mellitus and diabetic complications: A retrospective cohort study of US healthy adults
-
I. Mansi, C.R. Frei, C.P. Wang, and E.M. Mortensen Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults J Gen Intern Med 30 2015 1599 1610
-
(2015)
J Gen Intern Med
, vol.30
, pp. 1599-1610
-
-
Mansi, I.1
Frei, C.R.2
Wang, C.P.3
Mortensen, E.M.4
-
12
-
-
84958867600
-
-
Office of the Assistant Secretary of Defense for Health Affairs (OSAD-HA) TRICARE Management Activity (TMA) Human Research Protection Program (HRPP) Available at: Accessed on March 16, 2015
-
Guide for DoD Researchers on Using MHS Data 2012 Office of the Assistant Secretary of Defense for Health Affairs (OSAD-HA) TRICARE Management Activity (TMA) Human Research Protection Program (HRPP) Available at: http://health.mil/Reference-Center/Publications/2012/10/10/Guide-for-DoD-Researchers-on-Using-MHS-Data Accessed on March 16, 2015
-
(2012)
Guide for DoD Researchers on Using MHS Data
-
-
-
13
-
-
33947374141
-
-
U.S. Agency for Healthcare Research and Quality Available at: Accessed on March 16, 2015
-
Clinical Classifications Software (CCS) for ICD-9-cm 2012 U.S. Agency for Healthcare Research and Quality Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp Accessed on March 16, 2015
-
(2012)
Clinical Classifications Software (CCS) for ICD-9-cm
-
-
-
15
-
-
0003496412
-
-
Agency for Health Care Policy and Research Rockville, MD AHCPR Pub. No. 98-0049 1998
-
A. Elixhauser, C. Steiner, and C. Whittington Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995. Healthcare Cost and Utilization Project, HCUP 3 Research Note 1998 Agency for Health Care Policy and Research Rockville, MD AHCPR Pub. No. 98-0049 1998
-
(1998)
Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995. Healthcare Cost and Utilization Project, HCUP 3 Research Note
-
-
Elixhauser, A.1
Steiner, C.2
Whittington, C.3
-
16
-
-
84876692093
-
Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records
-
M. Liu, E.R. McPeek Hinz, M.E. Matheny, J.C. Denny, J.S. Schildcrout, R.A. Miller, and H. Xu Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records J Am Med Inform Assoc 20 2013 420 426
-
(2013)
J Am Med Inform Assoc
, vol.20
, pp. 420-426
-
-
Liu, M.1
McPeek Hinz, E.R.2
Matheny, M.E.3
Denny, J.C.4
Schildcrout, J.S.5
Miller, R.A.6
Xu, H.7
-
17
-
-
41149096954
-
Regression tree boosting to adjust health care cost predictions for diagnostic mix
-
J.W. Robinson Regression tree boosting to adjust health care cost predictions for diagnostic mix Health Serv Res 43 2008 755 772
-
(2008)
Health Serv Res
, vol.43
, pp. 755-772
-
-
Robinson, J.W.1
-
18
-
-
0026639706
-
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
-
R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 613-619
-
-
Deyo, R.A.1
Cherkin, D.C.2
Ciol, M.A.3
-
20
-
-
0036242532
-
Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies
-
R. Bender, and M. Blettner Calculating the "number needed to be exposed" with adjustment for confounding variables in epidemiological studies J Clin Epidemiol 55 2002 525 530
-
(2002)
J Clin Epidemiol
, vol.55
, pp. 525-530
-
-
Bender, R.1
Blettner, M.2
-
21
-
-
84923820824
-
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4
-
D.Q. Li, R. Kim, E. McArthur, J.L. Fleet, D.G. Bailey, D. Juurlink, S.Z. Shariff, T. Gomes, M. Mamdani, S. Gandhi, S. Dixon, and A.X. Garg Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4 CMAJ 187 2015 174 180
-
(2015)
CMAJ
, vol.187
, pp. 174-180
-
-
Li, D.Q.1
Kim, R.2
McArthur, E.3
Fleet, J.L.4
Bailey, D.G.5
Juurlink, D.6
Shariff, S.Z.7
Gomes, T.8
Mamdani, M.9
Gandhi, S.10
Dixon, S.11
Garg, A.X.12
-
23
-
-
3042604519
-
Dangers of rosuvastatin identified before and after FDA approval
-
S.M. Wolfe Dangers of rosuvastatin identified before and after FDA approval Lancet 363 2004 2189 2190
-
(2004)
Lancet
, vol.363
, pp. 2189-2190
-
-
Wolfe, S.M.1
-
24
-
-
70350121639
-
Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: An analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)
-
H.M. Colhoun, D.J. Betteridge, P.N. Durrington, G.A. Hitman, H.A. Neil, S.J. Livingstone, V. Charlton-Menys, D.A. DeMicco, J.H. Fuller CARDS Investigators Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS) Am J Kidney Dis 54 2009 810 819
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 810-819
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
Charlton-Menys, V.7
DeMicco, D.A.8
Fuller, J.H.9
-
25
-
-
77949332406
-
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention - An Intervention Trial Evaluating Rosuvastatin) trial
-
P.M. Ridker, J. MacFadyen, M. Cressman, and R.J. Glynn Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention - an Intervention Trial Evaluating Rosuvastatin) trial J Am Coll Cardiol 55 2010 1266 1273
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1266-1273
-
-
Ridker, P.M.1
MacFadyen, J.2
Cressman, M.3
Glynn, R.J.4
-
26
-
-
64749101006
-
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD
-
M.J. Koren, M.H. Davidson, D.J. Wilson, R.S. Fayyad, A. Zuckerman, D.P. Reed ALLIANCE Investigators Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD Am J Kidney Dis 53 2009 741 750
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 741-750
-
-
Koren, M.J.1
Davidson, M.H.2
Wilson, D.J.3
Fayyad, R.S.4
Zuckerman, A.5
Reed, D.P.6
-
27
-
-
1542298565
-
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study
-
V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivanidis, V.I. Bouloukos, and M. Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study J Clin Pathol 57 2004 728 734
-
(2004)
J Clin Pathol
, vol.57
, pp. 728-734
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Papageorgiou, A.A.3
Symeonidis, A.N.4
Pehlivanidis, A.N.5
Bouloukos, V.I.6
Elisaf, M.7
-
28
-
-
38449119409
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
-
J. Shepherd, J.J. Kastelein, V. Bittner, P. Deedwania, A. Breazna, S. Dobson, D.J. Wilson, A. Zuckerman, N.K. Wenger Treating to New Targets Investigators Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study Clin J Am Soc Nephrol 2 2007 1131 1139
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 1131-1139
-
-
Shepherd, J.1
Kastelein, J.J.2
Bittner, V.3
Deedwania, P.4
Breazna, A.5
Dobson, S.6
Wilson, D.J.7
Zuckerman, A.8
Wenger, N.K.9
-
29
-
-
84887210473
-
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
-
D. Nikolic, M. Banach, S. Nikfar, P. Salari, D.P. Mikhailidis, P.P. Toth, M. Abdollahi, K.K. Ray, M.J. Pencina, J. Malyszko, J. Rysz, M. Rizzo Lipid and Blood Pressure Meta-Analysis Collaboration Group A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 168 2013 5437 5447
-
(2013)
Int J Cardiol
, vol.168
, pp. 5437-5447
-
-
Nikolic, D.1
Banach, M.2
Nikfar, S.3
Salari, P.4
Mikhailidis, D.P.5
Toth, P.P.6
Abdollahi, M.7
Ray, K.K.8
Pencina, M.J.9
Malyszko, J.10
Rysz, J.11
Rizzo, M.12
-
30
-
-
84939973885
-
Should we use statins in all patients with chronic kidney disease without dialysis therapy? the current state of knowledge
-
J. Rysz, A. Gluba-Brzozka, M. Banach, and A. Wiecek Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge Int Urol Nephrol 47 2015 805 813
-
(2015)
Int Urol Nephrol
, vol.47
, pp. 805-813
-
-
Rysz, J.1
Gluba-Brzozka, A.2
Banach, M.3
Wiecek, A.4
|